Related Experiment Video
Updated: Jul 4, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Polygenic risk score translation across diverse populations
1Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor-HCFMUSP), São Paulo, Brazil.
Polygenic risk scores (PRSs) show promise for cardiovascular disease risk but perform poorly in diverse populations due to ancestry bias. Developing multi-ancestry and ancestry-aware models is crucial for equitable clinical translation.
Area of Science:
- Genetics and Genomics
- Cardiovascular Medicine
- Precision Public Health
Background:
- Polygenic risk scores (PRSs) are valuable for cardiovascular and cardiometabolic disease risk stratification.
- Current PRSs are primarily derived from European-ancestry datasets, limiting their effectiveness in diverse and admixed populations.
- This ancestry bias stems from variations in allele frequencies, linkage disequilibrium, and effect sizes across populations.
Purpose of the Study:
- To review methodological and translational advancements in PRS development across diverse populations.
- To emphasize progress in coronary artery disease (CAD), blood pressure, hypertension, type 2 diabetes, obesity, and atrial fibrillation.
- To highlight the importance of multi-ancestry and ancestry-aware models for equitable PRS application.
Main Methods:
- Review of recent literature on PRS development and validation in diverse populations.
- Examination of single-ancestry versus multi-ancestry PRS frameworks.
- Analysis of emerging methods for admixed genomes, including ancestry deconvolution and local-ancestry-aware models.
Main Results:
- Broader discovery resources and ancestry-aware methods improve PRS predictive performance across traits.
- Coronary artery disease (CAD) shows the most mature evidence for clinical gains from multi-ancestry PRSs.
- Progress is uneven across phenotypes, with blood pressure, hypertension, and type 2 diabetes facing calibration and implementation challenges; obesity and atrial fibrillation are rapidly advancing but less translationally ready.
Conclusions:
- Admixed and underrepresented populations are essential for developing robust and generalizable PRS models.
- Future precision cardiovascular medicine requires PRS models that are calibrated, interpretable, and clinically useful across diverse populations.
- Addressing ancestry bias is critical for the equitable clinical translation of PRSs in cardiovascular risk assessment.
Related Concept Videos
Polygenic Traits
Polygenic Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

